CFDA Commissioner Describes Hurdles, Roadmap To Drug Safety In China
This article was originally published in PharmAsia News
Executive Summary
China FDA’s Commissioner Zhang Yong discussed China’s drug safety challenges and said the country still faces hurdles including developing a pharma integrity system.